Autophagy inhibition overcomes sorafenib resistance in S45F‐mutated desmoid tumors-Reference-Cited by-同舟云学术

Autophagy inhibition overcomes sorafenib resistance in S45F‐mutated desmoid tumors

Published:2019-04-12 Issue: Volume: Page:
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Braggio Danielle¹²^ORCID,Koller David¹²,Jin Feng³,Siva Nanda⁴,Zewdu Abeba¹²,Lopez Gonzalo¹²,Batte Kara¹²,Casadei Lucia¹²,Welliver Meng³,Strohecker Anne M.²⁵⁶,Lev Dina⁷⁸,Pollock Raphael E.¹²

Affiliation:

1. Program in Translational Therapeutics The James Comprehensive Cancer Center, The Ohio State University Columbus Ohio

2. Department of Surgery The Ohio State University Columbus Ohio

3. Department of Radiation Oncology The Ohio State University Columbus Ohio

4. Department of Chemical and Biomedical Engineering West Virginia University Statler College of Engineering and Mineral Resources Morgantown West Virginia

5. Program in Molecular Biology and Cancer Genetics The James Comprehensive Cancer Center, The Ohio State University Columbus Ohio

6. Department of Cancer Biology and Genetics, College of Medicine The Ohio State University Columbus Ohio

7. Department of General Surgery B Sheba Medical Center Tel Aviv Israel

8. Tel Aviv University Tel Aviv Israel

Funder

Desmoid Tumor Research Foundation

National Cancer Institute

National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32120

Reference31 articles.

1. Desmoid tumors: need for an individualized approach;De Bree E;Expert Rev Anticancer Ther,2009

2. Desmoid tumor: current multidisciplinary approaches;Berri RN;Ann Plast Surg,2011

3. Increased beta‐catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors);Alman BA;Am J Pathol,1997

4. An update on the management of sporadic desmoid‐type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG);Kasper B;Ann Oncol,2017

5. Low‐dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis;Azzarelli A;Cancer,2001

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel insights into biomarkers of progression in Desmoid tumor;Frontiers in Oncology;2023-08-03

2. Update on Familial Adenomatous Polyposis-Associated Desmoid Tumors;Clinics in Colon and Rectal Surgery;2023-04-17

3. Preclinical efficacy of the Wnt/β-catenin pathway inhibitor BC2059 for the treatment of desmoid tumors;PLOS ONE;2022-10-14

4. In desmoid-type fibromatosis cells sorafenib induces ferroptosis and apoptosis, which are enhanced by autophagy inhibition;European Journal of Surgical Oncology;2022-07

5. Microwave radiation induces neuronal autophagy through miR-30a-5p/AMPKα2 signal pathway;Bioscience Reports;2022-04